FDA Inspection 696010 — Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center — FEI 1273763

The FDA completed an inspection of Beth Israel Deaconess Medical Center on October 26, 2010 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 26, 2010
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boston, MA (United States)

Citations

IDCFRDescription
6721 CFR 606.65(e)Following manufacturer's instructions
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs